Company news

AdAlta Ltd. news in 2020

AdAlta Ltd.'s news releases, calls and decks from 2020, newest first.

View company

Phase I HV extension to explore encouraging results

December 13, 2020

AGM Presentation

November 25, 2020

AusBiotech presentation including Phase I status update

October 26, 2020

Investor Presentation - BIO investor forum

October 9, 2020

GE Healthcare collaboration progresses

September 20, 2020

Non-renounceable Rights Issue Offer

August 18, 2020

Placement and Rights Offer

August 10, 2020

Investor presentation including future milestones

July 29, 2020

First participants treated in AD-214 Phase I trial

July 23, 2020

Supportive US FDA pre-IND meeting results for AD-214

July 19, 2020

AdAlta receives approval to commence AD-214 Phase I trial

June 9, 2020

Business update and COVID-19 response

March 30, 2020

Board changes and R&D Tax Incentive advance received

March 26, 2020

Investor Briefing - Strategic Plan

March 2, 2020

AD-214 effective in gold standard pre-clinical animal model

March 1, 2020

Appendix 4C - quarterly

January 30, 2020

AdAlta Granted US Patent for AD-214

January 29, 2020

AD-214 Phase I strategy and timing update

January 13, 2020

Decks in 2020